Figure 3From: Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse Conditioning regimens for haploidentical transplantation. For logistical reasons the irradiation was applied either before or after the chemotherapy. Stem cells were infused on day 0 in both patients. The second patients received donor-derived NK cells on day +1. In the first patient, NK cells were withheld until day +55 because of concerns regarding graft-versus-host disease due to the relatively high CD3+ cell content.Back to article page